Varian IMRT Technology Makes Investors Beam; Stock Up 18% In Q2
This article was originally published in The Gray Sheet
Executive Summary
The growing demand for advanced radiation therapy systems in the U.S. combined with a predictable revenue stream made Varian Medical Systems an investor favorite in the second quarter. The firm's stock price rose 10.70 points (17.6%) during the three months ended June 29 to $71.50.